CAR-mediated repression of Foxo1 transcriptional activity regulates the cell cycle inhibitor p21 in mouse livers
- 1 July 2014
- journal article
- Published by Elsevier in Toxicology
- Vol. 321, 73-79
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- MYC on the Path to CancerCell, 2012
- Synaptic NMDAR activity suppresses FOXO1 expression via a cis-acting FOXO binding site: FOXO1 is a FOXO target geneChannels, 2009
- C‐Myc and its target FoxM1 are critical downstream effectors of constitutive androstane receptor (CAR) mediated direct liver hyperplasia†Hepatology, 2008
- FOXO1 Represses Peroxisome Proliferator-activated Receptor-γ1 and -γ2 Gene Promoters in Primary AdipocytesJournal of Biological Chemistry, 2006
- Gadd45β Is Induced Through a CAR-Dependent, TNF-Independent Pathway in Murine Liver Hyperplasia * #Hepatology, 2005
- Cell cycle regulation and hepatocarcinogenesisCancer Biology & Therapy, 2004
- Regulation of PGC-1 Promoter Activity by Protein Kinase B and the Forkhead Transcription Factor FKHRDiabetes, 2003
- Phosphorylation of Serine 256 by Protein Kinase B Disrupts Transactivation by FKHR and Mediates Effects of Insulin on Insulin-like Growth Factor-binding Protein-1 Promoter Activity through a Conserved Insulin Response SequenceJournal of Biological Chemistry, 1999
- Involvement of p21 and p27 in the regulation of CDK activity and cell cycle progression in the regenerating liverOncogene, 1998
- Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450Biochemical Pharmacology, 1985